Skip to main content
SpringerLink
Log in
Book cover

Lung Cancer pp 43–74Cite as

Lung cancer chemoprevention

  • Chapter

Part of the book series: Cancer Treatment and Research ((CTAR,volume 72))

Abstract

Cancer chemoprevention is in a phase of extensive development, and the results achieved so far are particularly promising in the field of lung and upper aerodigestive tract carcinogenesis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   429.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   549.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Cancer Institute. Smoking, Tobacco, and Cancer Program 1985–89 Status Report. U.S. Department of Health and Human Services, PHS NIH Publication No. 90-3107.

    Google Scholar 

  2. Greenwald P, Stern HR. 1992. Role of biology and prevention in aerodigestive tract cancers. J Natl Cancer Inst Monogr 13:3–14.

    PubMed  Google Scholar 

  3. Parkin DM, Pisani P, Ferlay J. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–605.

    Article  PubMed  CAS  Google Scholar 

  4. Bjelke E. 1975. Dietary vitamin A and human lung cancer. Int J Cancer 15:561–565.

    Article  PubMed  CAS  Google Scholar 

  5. Mettlin C, Saxon G, Swanson M. 1979. Vitamin and lung cancer. J Natl Cancer Inst 62:1435–1438.

    PubMed  CAS  Google Scholar 

  6. MacLennan R, Da Costa J, Day NE, Law CH, Ng YK, Shanmugaratnam K. 1977. Risk factors for lung cancer in Singapore Chinese, a population with high female incidence rates. Int J Cancer 20:854–860.

    Article  PubMed  CAS  Google Scholar 

  7. Gregor A, Lee PN, Roe FJC, Wilson MJ, Melton A. 1980. Comparison of dietary histories in lung cancer cases and controls with special reference to vitamin A. Nutr Cancer 2:93–97.

    Article  Google Scholar 

  8. Hirayama T. 1979. Diet and cancer. Nutr Cancer 1:67–80.

    Article  Google Scholar 

  9. Shekelle RB, Lepper M, Liu S, Maliza C, Raynor WJ, et al. 1981. Dietary vitamin A and risk of cancer in the western electric study. Lancet 2:1185–1189.

    Article  PubMed  CAS  Google Scholar 

  10. Kvale G, Bjelke E, Gart JJ. 1983. Dietary habits and lung cancer. Int J Cancer 31:397–405.

    Article  PubMed  CAS  Google Scholar 

  11. Hinds MW, Kolonel LN, Hankin JH, Lee J. 1984. Dietary vitamin A, carotene, vitamin C and risk of lung cancer in Hawaii. Am J Epidemiol 119:227–236.

    PubMed  CAS  Google Scholar 

  12. Ziegler RG, Mason TJ, Stemhagen A, Hoover R, Schoenberg JB, et al. 1984. Dietary carotene and vitamin A and risk of lung cancer among white men in New Jersey. J Natl Cancer Inst 73:1429–1435.

    PubMed  CAS  Google Scholar 

  13. Samet JM, Skipper BJ, Humble CG, Pathak DR. 1985. Lung cancer risk and vitamin A consumption in New Mexico. Am Rev Respir Dis 131:198–202.

    PubMed  CAS  Google Scholar 

  14. Middleton B, Byers T, Marshall J, Graham S. 1986. Dietary vitamin A and cancer — a multisite case-control study. Nutr Cancer 8:107–116.

    Article  PubMed  CAS  Google Scholar 

  15. Pisani P, Berrino F, Macaluso M, Pastorino U, Crosignani P. 1986. Carrots, green vegetables and lung cancer: a case-control study. Int J Epidemiol 15:463–468.

    Article  PubMed  CAS  Google Scholar 

  16. Le Marchand L, Yoshizawa CN, Kolonel LN, Hankin JH, Goodman MT. 1989. Vegetable consumption and lung cancer risk: a population-based case-control study in Hawaii. J Natl Cancer Inst 81:1158–1164.

    Article  Google Scholar 

  17. Basu TK, Donaldson D, Jenner M, Williams DC, Sakula A. 1976. Plasma vitamin A in patients with bronchial carcinoma. Br J Cancer 33:119–121.

    Article  PubMed  CAS  Google Scholar 

  18. Atukorala S, Basu TK, Dickerson JVT, Donaldson D, Sakula A. 1979. Vitamin A, zinc and lung cancer. Br J Cancer 40:927–931.

    Article  PubMed  CAS  Google Scholar 

  19. Wald N, Idle M, Boreham J, Bailey A. 1980. Low serum-vitamin A and subsequent risk of cancer: preliminary results of a prospective study. Lancet 2:813–816.

    Article  PubMed  CAS  Google Scholar 

  20. Kark J, Smith AH, Switzer BR, Harnes CG. 1981. Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J Natl Cancer Inst 66:7–15.

    PubMed  CAS  Google Scholar 

  21. Peleg I, Heyden S, Knowles M, Harnes CG. 1984. Serum retinol and risk of subsequent cancer: extension of the Evans County, Georgia, study. J Natl Cancer Inst 73:1455–1458.

    PubMed  CAS  Google Scholar 

  22. Willett WC, Frank Polk B, Underwood BA, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames G. 1984. Relations of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med N Engl J Med 310:430–434.

    CAS  Google Scholar 

  23. Stahelin HB, Rosel F, Buess E, Brubacher G. 1984. Cancer, vitamins and plasma lipids: prospective Basel study. J Natl Cancer Inst 73:1463–1468.

    PubMed  CAS  Google Scholar 

  24. Salonen T, Salonen R, Lappetelainen R, Maenpaa P, Alfthan G, Puska P. 1985. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J 290:417–420.

    Article  CAS  Google Scholar 

  25. Nomura AM, Stemmermann GN, Heilbrun LK, Salked RM, Vuilleumier JP. 1985. Serum vitamin levels and risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res 45:2369–2372.

    PubMed  CAS  Google Scholar 

  26. Friedman GD, Blaner WS, Goodman DS. 1986. Serum retinol and retinol binding protein levels do not predict subsequent lung cancer. Am J Epidemiol 123:781–789.

    PubMed  CAS  Google Scholar 

  27. Menkes MS, Comstock GV, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. 1986. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 315:1250–1254.

    Article  PubMed  CAS  Google Scholar 

  28. Connett JE, Kuller LH, Kjelsberg MO, Polk BF, Collins G, Rider A, Hulley SB. 1989. Relationship between carotenoids and cancer. The Multiple Risk Factor Intervention Trial (MRFIT) Study. Cancer 64:126–134.

    Article  PubMed  CAS  Google Scholar 

  29. Kune GA, Kune S, Watson LF, Pierce R, Field B, Vitetta L, Merenstein D, Hayes A, Irving L. 1989. Serum levels of beta-carotene, vitamin A, and zinc in male lung cancer cases and controls. Nutr Cancer 12:169–176.

    Article  PubMed  CAS  Google Scholar 

  30. Gridley G, McLaughlin JK, Block G, Blot WJ, Gluch M, Fraumeni JF. 1992. Vitamin supplement use and reduced risk of oral and pharyngeal cancer. Am J Epidemiol 135: 1083–1092.

    PubMed  CAS  Google Scholar 

  31. Block G, Patterson B, Subar A. 1992. Fruit, vegetables and cancer prevention: a review of the epidemiologic evidence. Nutr Cancer 18:1–29.

    Article  PubMed  CAS  Google Scholar 

  32. Bertram JS, Kolonel LN, Meyskens FL. 1987. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res 47:3012–3031.

    PubMed  CAS  Google Scholar 

  33. Lippman SM, Kessler JF, Meyskens FL. 1987. Retinoids as preventive and therapeutic anticancer agents (part II). Cancer Treat Rep 71:493–515.

    PubMed  CAS  Google Scholar 

  34. Sporn MB, Newton NL. 1979. Chemoprevention of cancer with retinoids. Fed Proc 38:2528–2534.

    PubMed  CAS  Google Scholar 

  35. Lotan R. 1980. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605:33–91.

    PubMed  CAS  Google Scholar 

  36. Wolbach SB, Howe PR. 1925. Tissue changes following deprivation of fat soluble A vitamin. J Exp Med 42:753–777.

    Article  PubMed  CAS  Google Scholar 

  37. Dowling JE, Wald J. 1960. The biological function of vitamin A acid. Proc Natl Acad Sci USA 46:587–608.

    Article  PubMed  CAS  Google Scholar 

  38. Thompson JN, Howell JM, Pitt GAJ. 1964. Vitamin A and reproduction in rats. Proc R Soc Lond 159:510–535.

    Article  PubMed  CAS  Google Scholar 

  39. Wong YC, Buck RC. 1971. An electron microscopic study of metaplasia of the rat trachéal epithelium in vitamin A deficiency. Lab Invest 24:55–56.

    PubMed  CAS  Google Scholar 

  40. Elias PM, Fritsch P, Lampe MA, Williams ML, Nemanic MK, Grayson S. 1980. Effects of systemic retinoids on epidermal barrier function, proliferation, structure and glycosylation. Clin Res 28:248–253.

    Google Scholar 

  41. Moon RC, Mc Cormick DL, Mehta RG. 1983. Inhibition of carcinogenesis by retinoids. Cancer Res 43:2469–2475.

    CAS  Google Scholar 

  42. Goodman DS. 1984. Vitamin A and retinoids in health and disease. N Engl J Med 310:1023–1031.

    Article  PubMed  CAS  Google Scholar 

  43. Jetten AM, Nervi C, Vollberg TM. Control of squamous differentiation in tracheo-bronchial and epidermal epithelial cells: role of retinoids. J Natl Cancer Inst Monogr 13:93–100.

    Google Scholar 

  44. Chu EW, Malmgen RA. 1965. An inhibitory effect of vitamin A on the introduction of tumors of forestomach and cervix in the Syrian hamster by carcinogenic policyclic hydrocarbons. Cancer Res 25:884–895.

    PubMed  CAS  Google Scholar 

  45. Bollag W. 1972. Prophylaxis of chemically induced benign and malignant epithelial tumors by vitamin A acid (retinoic acid). Eur J Cancer 8:689–693.

    Article  PubMed  CAS  Google Scholar 

  46. Nettesheim P, Williams PL. 1976. The influence of vitamin A on the susceptibility of the rat lung to 3-methylcholantrene. Int J Cancer 17:351–357.

    Article  PubMed  CAS  Google Scholar 

  47. Sporn MB, Squire RA, Brown CC, Smith GM, Wenk ML, Springer S. 1977. 13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat. Science 195:487–489.

    Article  PubMed  CAS  Google Scholar 

  48. Chopra DP, Wilkoff LJ. 1977. Beta-retinoic acid inhibits and reverses testosterone induced hyperplasia in mouse prostate organ cultures. Nature 265:339–341.

    Article  PubMed  CAS  Google Scholar 

  49. Bollag W. 1971. Therapy of chemically induced skin tumour of mice with vitamin A palmitate and vitamin A acid. Experientia 27:90–92.

    Article  PubMed  CAS  Google Scholar 

  50. Bollag W. 1975. Prophylaxis of chemically induced epithelial tumors with an aromatic retinoic acid analog. Eur J Cancer 11:721–724.

    Article  PubMed  CAS  Google Scholar 

  51. Lotan R, Giotta G, Nork E, Nicolson GL. 1978. Characterization of the inhibitory effects of retinoids on the vitro growth of two malignant murine melanomas. J Natl Cancer Inst 60:1935–1041.

    Google Scholar 

  52. Verma AK, Rice HM, Shapas BG, Boutwell RK. 1978. Inhibition of 13-tetradecanoyl-phorbol-13 acetate induced ornithine decarboxylase activity in mouse epidermis by vitamin A analogs (retinoids). Cancer Res 38:793–801.

    PubMed  CAS  Google Scholar 

  53. Saffiotti U, Montesano R, Sellakumar AR, Bork SA. 1967. Experimental cancer of the lung, inhibition by vitamin A of the induction of tracheobronchial metaplasia and squamous cell tumor. Cancer 20:857–864.

    Article  PubMed  CAS  Google Scholar 

  54. Cone MV, Nettesheim P. 1973. Effects of vitamin A on 3-methylcholanthrene-induced squamous metaplasias and early tumors in the respiratory tract of rats. J Natl Cancer Inst 50:1599–1606.

    PubMed  CAS  Google Scholar 

  55. Port CD, Sporn MB, Kauffmann DG. 1975. Prevention of lung cancer in hamsters by 13-cis retinoic acid. Proc Am Assoc Cancer Res 16:21.

    Google Scholar 

  56. Smith DM, Rogers AE, Newberne PM. 1975. Vitamin A and benzopyrene carcinogenesis in the respiratory tract of hamsters fed a semisynthetic diet. Cancer Res 35:1485–1488.

    PubMed  CAS  Google Scholar 

  57. Trown PW, Buck MJ, Hansen R. 1976. Inhibition of growth and regression of a transplantable rat chrondrosarcoma by three retinoids. Cancer Treat Rep 60:1647–1653.

    PubMed  CAS  Google Scholar 

  58. Lotan R. 1979. Different susceptibilities of human melanoma and breat carcinoma cell lines to retinoic acid-induced growth inhibition. Cancer Res 39:1014–1019.

    PubMed  CAS  Google Scholar 

  59. Todaro GJ, DeLarco JE, Sporn MB. 1978. Retinoid blocks phenotypic cell transformation produced by sarcoma growth factor. Nature 276:272–278.

    Article  PubMed  CAS  Google Scholar 

  60. Gensler HL, Matrisian LM, Bowden GT. 1985. Effect of retinoic acid on the late-stage promotion of transformation in JB6 mouse epidermal cells in culture. Cancer Res 45: 1922–1925.

    PubMed  CAS  Google Scholar 

  61. Tachibana K, Sone S, Tsubura E, Kishino Y. 1984. Stimulatory effect of vitamin A on tumoricidal activity of rat alveolar macrophages. Br J Cancer 49:343–348.

    Article  PubMed  CAS  Google Scholar 

  62. Floersheim GL, Bollag W. 1972. Accelerated rejection of skin homografts by vitamin A acid. Transplantation 14:564–567.

    Article  PubMed  CAS  Google Scholar 

  63. Dennert G. 1985. Immunostimulation by retinoic acid. In Retinoids, Differentiation and Disease (Ciba Foundation Symposium 113). Pitman: London, pp. 117–131.

    Google Scholar 

  64. Evans RM. 1988. The steroid and thyroid hormone receptor superfamily. Science 240: 889–895.

    Article  PubMed  CAS  Google Scholar 

  65. Parker MG. 1990. Structure and function of nuclear hormone receptors. Semin Cancer Biol 1:81–87.

    PubMed  CAS  Google Scholar 

  66. Lotan R, Clifford JL. 1990. Nuclear receptors for retinoids: mediators of retinoid effects on normal and malignant cells. Biomed Pharmacother 45:145–156.

    Article  Google Scholar 

  67. Leid M, Kastner P, Chambon P. 1992. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 17:427–433.

    Article  PubMed  CAS  Google Scholar 

  68. de The H, Marchio A, Tiollais P, Dejean A. 1989. Differential expression and ligand regulation of the retinoic acid receptor a and b genes. EMBO J 8:429–433.

    PubMed  Google Scholar 

  69. Hu L, Gudas LJ. 1990. Cyclic AMP analogs and retinoic acid influence the expression of retinoic acid receptor a, b, and g mRNAs in F9 teratocarcinoma cells. Mol Cell Biol 10:391–396.

    PubMed  CAS  Google Scholar 

  70. Clifford J, Petkovich M, Chambon P, Lotan R. 1990. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells. Mol Endocrinol 4:1546–1555.

    Article  PubMed  CAS  Google Scholar 

  71. Mattei MG, Riviere M, Krust A, Ingvarsson S, Vennstrom B, Islam MQ, Levan G, Kautner P, Zelent A, Chambon P, Szpirer J, Szpirer C. 1991. Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. Genomics 10:1061–1069.

    Article  PubMed  CAS  Google Scholar 

  72. de The H, Vivanco-Ruiz MdM, Tiollais P, Stunnenberg H, Dejean A. 1990. Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature 343:177–180.

    Article  PubMed  Google Scholar 

  73. Lehman JM, Dawson MI, Hobbs PD, Husmann M, Pfahl M. 1991. Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res 51:4804–4809.

    Google Scholar 

  74. De Flora S, Ramel C. 1988. Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. Mutat Res 202:285–306.

    Article  PubMed  Google Scholar 

  75. Shamberger RJ. 1976. Relationship of selenium to cancer. I. Inhibitory effect of selenium on carcinogenesis. J Natl Cancer Inst 44:931–936.

    Google Scholar 

  76. Horvath PM, Hip C. 1983. Synergistic effect of vitamin E and selenium on the chemoprevention of mammary carcinogenesis in rats. Cancer Res 43:5335–5341.

    PubMed  CAS  Google Scholar 

  77. Cerutti PA. 1985. Prooxidant states and tumor promotion. Science 227:375–381.

    Article  PubMed  CAS  Google Scholar 

  78. Birt DF, Lawson TA, Julius AD, Runice CE, Salmasi S. 1982. Inhibition by dietary selenium of colon cancer induced in the rat by bis(20xopropyl)nitrosamine. Cancer Res 42:4455–4459.

    PubMed  CAS  Google Scholar 

  79. Ip C. 1981. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res 41:4386–4390.

    PubMed  CAS  Google Scholar 

  80. Epstein JH. 1977. Effects of beta-carotene on ultraviolet induced cancer formation in the hairless mouse skin. Photochem Photobiol 25:211–213.

    Article  PubMed  CAS  Google Scholar 

  81. Mathews-Roth MM. 1982. Antitumor activity of beta-carotene, cathaxanthin and phytoene. Oncology 39:33–37.

    Article  PubMed  CAS  Google Scholar 

  82. Rettura G, Stratford F, Levenson SM, Seifter E. 1982. Prophylactic and therapeutic actions of supplemental beta-carotene in mice inoculated with CH3BA adenocarcinoma cells: lack of therapeutic action of supplemental ascorbic acid. J Natl Cancer Inst 69:73–77.

    PubMed  CAS  Google Scholar 

  83. Som S, Chatterjee M, Banerjee MR. 1984. Beta-carotene inhibition of 7,12-dimethyl-benzanthracene-induced transformation of murine mammary cells in vitro. Carcinogenesis 5:937–940.

    Article  PubMed  CAS  Google Scholar 

  84. Camoirano A, Badolati GS, Zanacchi P, Bagnasco M, De Flora S. 1988. Dual role of thiols in N-methyl-N’-nitro-N-nitrosoguanidine genotoxicity. Life Sci Adv Exp Oncol 7:21–25.

    Google Scholar 

  85. De Flora S, Camoirano A, Izzotti A, Zanacchi P, Bagnasco M, Cesarone CF. 1991. Antimutagenic and anticarcinogenic mechanisms of aminothiols. In Anticarcinogenesis and Radiation Protection III, F Nygaard and AC Upton (eds.). Plenum Press: New York, pp. 275–285.

    Chapter  Google Scholar 

  86. Izzotti A, Balansky R, Coscia N, Scatolini L, D’Agostini F, De Flora S. 1992. Chemo-prevention of smoke-related DNA adduct formation in rat lung and heart. Carcinogenesis 13:2187–2190.

    Article  PubMed  CAS  Google Scholar 

  87. De Flora S, Astengo M, Serra D, Benicelli C. 1986. Prevention of induced lung tumors in mice by dietary N-acetylcysteine. Cancer Lett 32:235–241.

    Article  PubMed  Google Scholar 

  88. Wilpart M, Speder D, Roberfroid M. 1986. Anti-initiation activity of N-acetylcysteine in experimental colonic carcinogenesis. Cancer Lett 31:319–324.

    Article  PubMed  CAS  Google Scholar 

  89. Ip C, Ganther HE. 1991. Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis 12:365–367.

    Article  PubMed  CAS  Google Scholar 

  90. Moon RC, Rao KV, Detrisac CJ, Kelloff GJ. 1992. Animal models for chemoprevention of respiratory cancer. Monogr Natl Cancer Inst (U.S.) 13:45–49.

    Google Scholar 

  91. Pastorino U, Soresi E, Clerici M, et al. 1988. Lung cancer chemoprevention with retinol palmitate. Acta Oncol 27:773–782.

    Article  PubMed  CAS  Google Scholar 

  92. Bauernfeind JC. 1980. The safe use of vitamin A: a report of the International Vitamin A Consultative Group (IVAG). The Nutrition Foundation, 888 17th St, NW, Washington, DC, 20006.

    Google Scholar 

  93. Bendich LL. 1989. Safety of vitamin A. Am J Clin Nutr 49:358–371.

    PubMed  CAS  Google Scholar 

  94. Rapaport HG, Herman H, Lehman E. 1942. Treatment of ichtyosis with vitamin A. J Pediatr 21:733–746.

    Article  Google Scholar 

  95. Frey JR, Schoch MA. 1952. Therapeutische versuche bei psoriasis mit vitamin A, zugleich ein beitrag zur A-hypervitaminose. Dermatologicala 104:80–86.

    Article  CAS  Google Scholar 

  96. Schimpf A, Jansen KH. 1972. Hochdosierte vitamin-A-therapie bei psoriasis und mycosis fungoides. Fortschr Ther 90:635–639.

    CAS  Google Scholar 

  97. Silverman S, Renstrup G, Pindborg J. 1963. Studies in oral leukoplakias: III. Effects of vitamin A comparing clinical, histopathological, cytologic, and hemathologic responses. Acta Odont Scand 21:271–292.

    Article  PubMed  Google Scholar 

  98. Korner WF, Vollm J. 1975. New aspects of the tolerance of retinol in humans. Int J Vit Nutr Res 45:363–372.

    CAS  Google Scholar 

  99. Pastorino U, Chiesa G, Infante M, et al. 1991. Safety of high-dose vitamin A. Randomized trial on lung cancer chemoprevention. Oncology 48:131–137.

    Article  PubMed  CAS  Google Scholar 

  100. Bollag W. 1983. Vitamin A and retinoid: from nutrition to pharmacotherapy in dermatology and oncology. Lancet 1:860–863.

    Article  PubMed  CAS  Google Scholar 

  101. Sporn MB, Dunlop NM, Newton DL, Henderson WR. 1976. Relationship between structure and activity of retinoids. Nature 263:110–113.

    Article  PubMed  CAS  Google Scholar 

  102. Peck GL, Olsen TG, Butkus D, Pandya M, Arnaud-Battandier J, Yoder F, Levis WR. 1979. Treatment of basal cell carcinomas with 13-cis retinoic acid. Proc Am Assoc Cancer Res 20:56.

    Google Scholar 

  103. Kamm JJ, Ashenfelter KO, Emann CW. 1984. Preclinical and clinical toxicology of selected retinoids. In The Retinoids, vol. 2, MB Sporn et al. (eds.). Academic Press: Orlando, FL, pp. 287–326.

    Google Scholar 

  104. Pennes DR, Ellis CN, Madison KC, Voorhees JJ, Martel W. 1984. Early skeletal hyperostosis secondary to 13-cis-retinoic acid. Am J Radiol 141:979–983.

    Google Scholar 

  105. Hong WK, Endicott J, Itri L, et al. 1986. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 315:1501–1505.

    Article  PubMed  CAS  Google Scholar 

  106. Sestili MA. 1985. Chemoprevention clinical trials. Problems and solutions. NIH Publication No. 85-2715.

    Google Scholar 

  107. Greenwald P, Sondik E, Lynch BS. 1986. Diet and chemoprevention in NCI’s research strategy to achieve national cancer control objectives. Annu Rev Public Health 7:267–291.

    Article  PubMed  CAS  Google Scholar 

  108. Sporn MB, Newton DL. 1979. Chemoprevention of cancer with retinoids. Fed Proc 38:2528–2534.

    PubMed  CAS  Google Scholar 

  109. Moon RC, Thompson HJ, Becci PL, et al. 1979. N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer. Cancer Res 39:1339–1346.

    PubMed  CAS  Google Scholar 

  110. Paulson JD, Oldham JW, Preston RF, et al. 1985. Lack of genotoxicity of the cancer chemopreventive agent N-(4-hydroxyphenyl)retinamide. Fund Appl Toxicol 5:144–150.

    Article  CAS  Google Scholar 

  111. Formelli F, Carsana R, Costa A, Buranelli F, Campa T, Dossena G, Magni A, Pizzichetta M. 1989. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Cancer Res 48:6149–6152.

    Google Scholar 

  112. Veronesi U, De Palo G, Costa A, et al. 1992. Chemoprevention of breast cancer with retinoids. INCI Monogr 12:93–97.

    Google Scholar 

  113. Berni R, Formelli F. 1992. In vitro interaction of fenretinide with plasma retinolbinding protein and its functional consequences. FEBS 308:43–45.

    Article  CAS  Google Scholar 

  114. Chiesa F, Tradati N, Marazza M, Rossi N, Boracchi P, Mariani L, Clerici M, Formelli F, Barzan L, Carrassi A, Pastorini A, Camerini T, Giardini R, Zurrida S, Minn FL, Costa A, DePalo G, Veronesi U. 1992. Prevention of local relapses and new localisations of oral leukoplachias with the synthetic retinoid fenretinide (4-HPR). Preliminary results. Oral Oncology — Eur J Cancer 28B:97–102.

    Article  CAS  Google Scholar 

  115. Stich HF, Rosin MP, Hornby AP. 1988. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 42:195–199.

    Article  PubMed  CAS  Google Scholar 

  116. Garewal HS, Meyskens FL, Killen D. 1990. Response of oral leukoplakia to beta-carotene. J Clin Oncol 8:1715–1720.

    PubMed  CAS  Google Scholar 

  117. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK. 1993. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 328:15–20.

    Article  PubMed  CAS  Google Scholar 

  118. Boman G, Bäcker U, Larsson S, Melander B, Wahlander L. 1983. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis 64:405–415.

    PubMed  CAS  Google Scholar 

  119. Heffner JE, Repine JE. 1989. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 140:531–554.

    Article  PubMed  CAS  Google Scholar 

  120. Flanagan RJ. 1987. The role of acetylcysteine in clinical toxicology. Med Toxicol 2:93–104.

    PubMed  CAS  Google Scholar 

  121. Miller LF, Rumack BH. 1983. Clinical safety of high oral doses of acetylcysteine. Semin Oncol 10(suppl 1):76–85.

    PubMed  CAS  Google Scholar 

  122. Geenwald P, Stern HR. 1992. Role of biology and prevention in aerodigestive tract cancer. J Natl Cancer Inst Monogr 13:3–14.

    Google Scholar 

  123. Kelloff GJ, Boone CW, Malone WF, Steele VE. 1992. Chemoprevention clinical trials. Mutat Res 267:291–295.

    Article  PubMed  CAS  Google Scholar 

  124. Dimitrov NV, Bennett JL, McMillan J, Perloff M, Leece CM, Malone W. 1992. Clinical pharmacology studies of oltipraz — a potential chemopreventive agent. Invest New Drugs 10:289–298.

    Article  PubMed  CAS  Google Scholar 

  125. Wattenberg LW, Bueding E. 1986. Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo(a)pyrene, diethylnitrosamine and uracil mustard. Carcinogenesis 7:1379–1381.

    Article  PubMed  CAS  Google Scholar 

  126. Rao CV, Tokomo K, Kelloff G, Reddy BS. 1991. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis 12:1051–1055.

    Article  PubMed  CAS  Google Scholar 

  127. Kensler TW, Groopman JD, Eaton DL, Curphey TJ, Roebuck BD. 1992. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis 13:95–100.

    Article  PubMed  CAS  Google Scholar 

  128. Pépin P, Bouchard L, Nicole P, Castonguay A. 1992. Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)l-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis 13:341–348.

    Article  PubMed  Google Scholar 

  129. Benson AB III. 1993. Oltipraz: a laboratory and clinical review. J Cell Biochem 17F:278–291.

    Article  Google Scholar 

  130. Carper SW, Tome ME, Fuller DJ, Chen JR, Harari PM, Gerner EW. 1991. Polyamine catabolism in rodent and human cells in culture. Biochem J 280:289–294.

    PubMed  CAS  Google Scholar 

  131. Rao CV, Tokumo K, Rigotty J, Zang E, Kelloff G, Reddy BS. 1991. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res 51:4528–4534.

    PubMed  CAS  Google Scholar 

  132. Kadmon D. 1992. Chemopreventiori in prostate cancer: the role of difluoromethylornithine (DFMO). J Cell Biochem Suppl 16H:122–127.

    Article  PubMed  CAS  Google Scholar 

  133. Zirvi KA, Atabek U. 1991. In vitro response of a human colon tumor xenograft and a lung adenocarcinoma cell line to alpha-difluoromethylornithine alone and in combination with 5-fluorouracil and doxorubicin. J Surg Oncol 48:34–38.

    Article  PubMed  CAS  Google Scholar 

  134. Croghan MK, Aickin MG, Meyskens FL. 1991. Dose-related alpha-difluoromethylornithine ototoxicity. Am J Clin Oncol 14:331–335.

    Article  PubMed  CAS  Google Scholar 

  135. Gerrish KE, Fuller DJ, Gerner EW, Gensler HL. 1993. Inhibition of DFMO-induced audiogenic seizures by chlordiazepoxide. Life Sci 52:1101–1108.

    Article  PubMed  CAS  Google Scholar 

  136. Doerr-O’Rourke K, Trushin N, Hecht SS, Stoner GD. 1991. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue. Carcinogenesis 12:1029–1034.

    Article  PubMed  Google Scholar 

  137. Morse MA, Reinhardt JC, Amin SG, Hecht SS, Stoner GD, Chung FL. 1990. Effect of dietary aromatic isothiocyanates fed subsequent to the administration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumorigenicity in mice. Cancer Lett 49:225–230.

    Article  PubMed  CAS  Google Scholar 

  138. Boukharta M, Jalbert G, Castonguay A. 1992. Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr Cancer 18:181–189.

    Article  PubMed  CAS  Google Scholar 

  139. Perchellet JP, Gali HU, Perchellet EM, Klish DS, Armbrust AD. 1992. Antitumor-promoting activities of tannic acid, ellagic acid, and several gallic acid derivatives in mouse skin. Basic Life Sci 59:783–801.

    PubMed  CAS  Google Scholar 

  140. Stoner GD, Morrissey DT, Heur YH, Daniel EM, Galati AJ, Wagner SA. 1991. Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus. Cancer Res 51:2063–2068.

    PubMed  CAS  Google Scholar 

  141. Albanes D, Virtamo J, Rauthalahti M, et al. 1986. Pilot study: The U.S. Finland lung cancer prevention trial. J Nutr Growth Cancer 3:207–214.

    Google Scholar 

  142. Hennekens CH. 1984. Issues in the design and conduct of clinical trials. J Natl Cancer Inst 73:1473–1476.

    PubMed  CAS  Google Scholar 

  143. Benner SE, Winn RJ, Lippman SM, Poland J, Hansen KS, Luna MA, Hong WK. 1993. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. J Natl Cancer Inst 85:44–47.

    Article  PubMed  CAS  Google Scholar 

  144. Lee JS, Benner SE, Lippman SM, Lee JJ, Ro JY, Lukeman JM, Morice RC, Peters EJ, Pang AC, Hittelman HM, Hong WK. 1993. A randomised placebo-controlled chemoprevention trial of 13-cis-retinoic acid (cRA) in bronchial squamous metaplasia. Proc ASCO 13:1117.

    Google Scholar 

  145. de Vries N. 1990. The magnitude of the problem. In Multiple Primary Tumors in the Head and Neck, N de Vries and JL Glukman (eds.). Thieme: Stuttgard pp. 1–29.

    Google Scholar 

  146. Hong WK, Bromer RH, Amato DA. 1985. Paterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality therapy. Cancer 56:1242–1245.

    Article  PubMed  CAS  Google Scholar 

  147. Slaughter DP, Southwick HW, Smejkal W. 1953. ‘Field cancerization’ in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 6:963–968.

    Article  PubMed  CAS  Google Scholar 

  148. McDonald S, Haie C, Rubin P, Nelson D, Divers LD. 1989. Second malignant tumors in patients with laryngeal carcinoma: diagnosis, treatment and prevention. Int J Radiat Oncol Biol Phys 17:457–465.

    Article  PubMed  CAS  Google Scholar 

  149. de Vries N, van der Waal I, Snow GB. 1986. Multiple primary tumors in oral cancer. Int J Maxillofac Surg 15:85–87.

    Article  Google Scholar 

  150. de Vries N, Snow GB. 1986. Multiple primary tumors in laryngeal cancer. J Laryngol Otol 100:915–917.

    Article  PubMed  Google Scholar 

  151. Fontana RS. 1977. Early diagnosis of lung cancer. Am Rev Respir Dis 116:399–402.

    PubMed  CAS  Google Scholar 

  152. Pairolero P, Williams DE, Bergstrahl EJ, Piehler JM, Bernatz PE, Payne SP. 1984. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 38:331–338.

    Article  PubMed  CAS  Google Scholar 

  153. Shields TW, Robinette CD. 1973. Long-term survivors after resection of bronchial carcinoma. Surg Gynecol Obstet 136:759–768.

    PubMed  CAS  Google Scholar 

  154. Auerbach O, Stout AP, Hammond EC, et al. 1967. Multiple primary bronchial carcinomas. Cancer 20:699.

    Article  PubMed  CAS  Google Scholar 

  155. Femeck BK, Flehinger BJ, Martini N. 1984. A retrospective analysis of 10-year survivors from carcinoma of the lung. Cancer 53(6): 1405–1408.

    Article  Google Scholar 

  156. Hong WK, Lippman JM, Itri L, et al. 1990. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 323:795–801.

    Article  PubMed  CAS  Google Scholar 

  157. Benner SE, Lee JS, Goepfert H, Hong WK. 1993. Long term follow up: 13-cis-retinoic acid (cRA) prevention of second primary tumors (SPT) following squamous cell carcinoma of the head and neck (SCCHN). Proc ASCO 12:900.

    Google Scholar 

  158. Bolla M, Lefur R, Ton Van J, Domange C, Badet JM, Koskas Y, Laplanche A. 1993. Prevention of second primary with etretinate in squamous cell carcinoma of oral cavity and oropharynx a randomized double blind study. Proc 2nd Int Cancer Chemo Prevention Conf (CCPC-93). Berlin, April 28–30, p. 76.

    Google Scholar 

  159. Pastorino U, Infante I, Maioli M, Chiesa G, Buyse M, Firket P, Rosmentz N, Clerici M, Soresi E, Valente M, Belloni PA, Ravasi G. 1993. Adjuvant treatment of stage I lung cancer with high dose vitamin A. J Clin Oncol 11:1216–1222.

    PubMed  CAS  Google Scholar 

  160. De Vries N, Van Zandwijk N, Pastorino U. 1991. The EUROSCAN Study. Br J Cancer 64:985–989.

    Article  PubMed  Google Scholar 

  161. Lippman SM, Benner SE, Hong WK. 1993. Chemoprevention strategies in lung carcinogenesis. Chest 103:15S–19S.

    PubMed  CAS  Google Scholar 

  162. Jin Y-S, Mandahl N, Heim S, Schuller H, Mitelman F. 1988. Isochromosomes i(8q) or i(9q) in three adenocarcinomas of the lung. Cancer Genet Cytogenet 33:11–17.

    Article  PubMed  CAS  Google Scholar 

  163. Bello MJ, Moreno S, Rey JA. 1989. Involvement of chromosomes 1, 3, and i(8q) in lung adenocarcinoma. Cancer Genet Cytogenet 38:133–135.

    Article  PubMed  CAS  Google Scholar 

  164. Lukeis R, Irving L, Garson M, Hasthorpe S. 1990. Cytogenetics of non-small cell lung cancer: Analysis of consistent non-random abnormalities. Genes Chrom Cancer 2:116–124.

    Article  PubMed  CAS  Google Scholar 

  165. Sozzi G, Miozzo M, Tagliabue E, Calderone C, Lombardi L, Pilotti S, Pastorino U, Pierotti MA, Della Porta G. 1991. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res 51:400–404.

    PubMed  CAS  Google Scholar 

  166. Wang Peng J, Knutsen T, Gazdar A, Steinberg SM, Oie H, Linnoila I, Mulshine J, Nau M, Minna JD. 1991. Non random structural and numerical chromosome changes in non-small cell lung cancer. Genes Chrom Cancer 3:168–188.

    Article  Google Scholar 

  167. Testa JR, Siegfried JM. 1992. Chromosome abnormalities in human non-small cell lung cancer. Cancer Res 52:2702s–2706s.

    PubMed  CAS  Google Scholar 

  168. Hendler FJ, Ozanne BW. 1984. Human squamous cell lung cancers express increased epidermal growth factor receptors. J Clin Invest 74:647–651.

    Article  PubMed  CAS  Google Scholar 

  169. Cerny T, Barnes DM, Hasleton P, Barber PV, Healy K, Gullick W, Thatcher N. 1986. Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br J Cancer 54:265–269.

    Article  PubMed  CAS  Google Scholar 

  170. Berger MS, Gullick WJ, Greenfield C, Evans S, Addis BJ, Waterfield MD. 1987. Epidermal growth factor receptors in lung tumors. J Pathol 152:297–307.

    Article  PubMed  CAS  Google Scholar 

  171. Volm M, Efferth T, Mattern J. 1992. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. Anticancer Res 12:11–20.

    PubMed  CAS  Google Scholar 

  172. Rodenhuis S, Slebos RJC, Boot AJM, Evers SG, Mooi WJ, Wagenaar SS, Van Bodegom PC, Bos JL. 1988. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the lung. Cancer Res 48:5738–5741.

    PubMed  CAS  Google Scholar 

  173. Slebos RJC, Kibbelaar RE, Dalesio O, Koolstra A, Stam J, Neifier CJLM, Wagenaar SS, Van der Schueren R, Van Zandwijk N, Mooi WJ, Bos JL, Rodenhuis S. 1990. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 323:561–565.

    Article  PubMed  CAS  Google Scholar 

  174. Mitsudomi T, Steinberg SM, Oie HK, Mulshine JL, Phelps R, Viallet J, Pass H, Minna JD, Gazdar AF. 1991. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res 51:4999–5002.

    PubMed  CAS  Google Scholar 

  175. Rodenhuis S, Slebos RJC. 1992. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 52:2665s-2669s.

    Google Scholar 

  176. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L, Robinson RA. 1990. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 50:5184–5187.

    PubMed  CAS  Google Scholar 

  177. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI, Williams WV, Cohen JA, Kern JA. 1990. Expression of the neu gene-encoded protein (p185neu) in human non-small cell carcinomas of the lung. Cancer Res 50:421–425.

    PubMed  CAS  Google Scholar 

  178. Tateishi M, Ishida T, Mitsudomi T, Kaneko S, Sugimachi K. 1991. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 27:1372–1375.

    Article  PubMed  CAS  Google Scholar 

  179. Shi D, He G, Cao S, Pan W, Zhang HZ, Yu D, Hung MC. 1992. Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer. Mol Carcinogen 5:213–218.

    Article  CAS  Google Scholar 

  180. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD. 1983. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306:194–196.

    Article  PubMed  CAS  Google Scholar 

  181. Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD. 1985. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature 318:69–73.

    Article  PubMed  CAS  Google Scholar 

  182. Johnson BE, Ihde D, Makuch RW, Gazdar AF, Carney DN, Oie H, Russell E, Nau MM, Minna JD. 1987. myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J Clin Invest 79:1629–1634.

    Article  PubMed  CAS  Google Scholar 

  183. Shiraishi M, Noguchi M, Shimosato Y, Sekiya T. 1989. Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res 49:6474–6479.

    PubMed  CAS  Google Scholar 

  184. Harbour JW, Lai S-L, Whang-Peng J, Gazdar AD, Minna JD, Kaye FJ. 1988. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353–357.

    Article  PubMed  CAS  Google Scholar 

  185. Horowitz JM, Park SH, Bogenmann E, Cheng J-C, Yandell DW, Daye FJ, Minna JD, Dryja TP, Weinberg RA. 1990. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA 87:2775–2779.

    Article  PubMed  CAS  Google Scholar 

  186. Houle B, Leduc F, Bradley WEC. 1991. Implication of RARB in epidermoid (squamous) lung cancer. Genes Chrom Cancer 3:358–366.

    Article  PubMed  CAS  Google Scholar 

  187. Tsuchiya E, Nakamura Y, Weng S-Y, Nakagawa K, Tsuchiya S, Sugano H, Kitagawa T. 1992. Allelotype of non-small cell lung carcinoma — Comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52:2478–2481.

    PubMed  CAS  Google Scholar 

  188. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, Suyama M, Takagi H, Nakaraura Y, Takahashi T. 1992. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 7:445–449.

    PubMed  CAS  Google Scholar 

  189. Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ, Neel BG. 1991. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene 6:1859–1868.

    PubMed  CAS  Google Scholar 

  190. Iggo R, Gatter K, Bartek J, Lane D, Harris AL. 1990. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675–679.

    Article  PubMed  CAS  Google Scholar 

  191. Chiba I, Takahashi T, Nau M, D’Amico D, Curiel D, Mitsudomi TDB, Carbone D, Piantadosi S, Koga H, Reissmann P, Slamon D, Holmes E, Minna J. 1990. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5:1603–1610.

    PubMed  CAS  Google Scholar 

  192. Takahashi T, Takahashi T, Suzuki H, Hida T, Sekido Y, Ariyoshi Y, Ueda R. 1991. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 6:1775–1778.

    PubMed  CAS  Google Scholar 

  193. D’Amico D, Carbone D, Mitsudomi T, Nau M, Fedorko J, Russell E, Johnson B, Buchhagen D, Bodner S, Phelps R, Gazdar A, Minna JD. 1992. High frequency of somatically acquired p53 mutations in small cell lung cancer cell lines and tumors. Oncogene cell 7:339–346.

    Google Scholar 

  194. Miller CW, Simon K, Aslo Kok K, Yokota J, Buys CH, Terada M, Koeffler HP. 1992. p53 mutations in human lung tumors. Cancer Res 52:1695–1698.

    PubMed  CAS  Google Scholar 

  195. Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T, Ueda R. 1992. p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 52:734–736.

    PubMed  CAS  Google Scholar 

  196. Kishimoto Y, Murakami Y, Shiraishi M, Hayashi K, Sekiya T. 1992. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res 52:4799–4804.

    PubMed  CAS  Google Scholar 

  197. Hiyoshi H, Matsuno Y, Kato H, Shimosato Y, Hirohashi S. 1992. Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer. Jpn J Cancer Res 83:101–106.

    Article  PubMed  CAS  Google Scholar 

  198. Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, Shimokata K, Yamakawa K, Nakamura Y, Ueda R, Takahashi T. 1993. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res 53(1):1–4.

    PubMed  CAS  Google Scholar 

  199. Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. 1992. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52:4828–4831.

    PubMed  CAS  Google Scholar 

  200. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM, Rabbitts P. 1992. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7:1989–1997.

    PubMed  CAS  Google Scholar 

  201. Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, Della Porta G, Pierotti MA. 1992. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. Cancer Res 52:6079–6082.

    PubMed  CAS  Google Scholar 

  202. Pastorino U, Sozzi G, Miozzo M, Tagliabue E, Pilotti S, Pierotti MA. 1993. Genetic changes in lung cancer. J Cell Biochem 17F:237–248.

    Article  CAS  Google Scholar 

  203. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA. 1993. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53:1676–1683.

    PubMed  CAS  Google Scholar 

  204. Lee JS, Lippman SM, Hong WK, Ro JY, Kim SY, Lotan R, Hittelman WN. 1992. Determination of biomarkers for intermediate end points in chemoprevention trials. Cancer Res 52(9)(Suppl):2707s–2710s.

    PubMed  CAS  Google Scholar 

  205. Stich HF, Rosin MP, Hornby AP. 1988. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer 42:195–199.

    Article  PubMed  CAS  Google Scholar 

  206. Lippman SM, Peters EJ, Wargovich MJ, et al. 1990. Bronchial micronuclei as a marker of an early stage of carcinogenesis in the human tracheobronchial epithelium. Int J Cancer 45:811–815.

    Article  PubMed  CAS  Google Scholar 

  207. Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF, Hittelman WN. 1991. Expression of blood-group antigen A — a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 324:1084–1090.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Ugo Pastorino
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Oncology 5074, Rigshospitalet, 9 Blegdamsvej, DK-2100, Copenhagen, Denmark

    Heine H. Hansen

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pastorino, U. (1994). Lung cancer chemoprevention. In: Hansen, H.H. (eds) Lung Cancer. Cancer Treatment and Research, vol 72. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2630-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2630-8_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6128-2

  • Online ISBN: 978-1-4615-2630-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation